Esocon 40 mg/vial (IV Injection)
40 mg vial: ৳ 65.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Biopharma limited |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Treatment of Zollinger-Ellison Syndrome
- Treatment of acid-related Dyspepsia
- Treatment of Duodenal and Gastric ulcers
Pharmacology
- Proton pump inhibitor
- Suppression of gastric acid secretion
- Inhibition of H+/K+-ATPase
- Better acid control than racemic proton pump inhibitors
- Enteric-coated pellet formulation
- Peak plasma levels at approximately 1.5 hours
- Metabolized in the liver by CYP enzyme system
- Extensive plasma protein binding
- Systemic bioavailability of approximately 90%
- 97% plasma protein binding
- Plasma elimination half-life of approximately 1-1.5 hours
Dosage
- Oral dosage form
- 20 mg or 40 mg Once Daily for 4-8 Weeks for healing of erosive esophagitis
- 20 mg Once Daily for maintenance of healing of erosive esophagitis
- 20 mg Once Daily for symptomatic GERD
- Triple Therapy for Helicobacter pylori eradication
- 20-80 mg once daily for Zollinger-Ellison Syndrome
- 20-40 mg once daily for acid-related Dyspepsia
- 20 mg once daily for 2-4 weeks for Duodenal ulcer
- 20-40 mg once daily for 4-8 weeks for Gastric ulcer
- IV Injection or infusion for specific conditions and age groups
Administration
- Swallow whole and take one hour before a meal for tablet or capsule
- Specific instructions for oral suspension
- Preparation of IV injection solution
- Specific administration times and conditions
Interaction
- Metabolized in the liver by CYP2C19 and CYP3A4
- Inhibition of gastric acid secretion
- Possible interference with CYP2C19 and CYP3A4 substrates
- Potential drug interaction with oral contraceptives, diazepam, phenytoin, or quinidine
- Interactions with clarithromycin and amoxicillin
Contraindications
- Known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- No teratogenic effects in animal studies
- Excretion of esomeprazole in milk not studied
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Specific instructions for patients with difficulty swallowing capsules
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- No overall differences in safety and efficacy in geriatric use
- No dosage adjustment for patients with mild to moderate hepatic insufficiency
- Expected unaltered pharmacokinetics in patients with renal impairment
Overdose Effects
- Lethal effects observed in animal studies for high doses
Storage Conditions
- Temperature not exceeding 30°C
- Protection from light and moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C17H19N3O3S
Common Questions about Esocon 40 mg/vial Injection
- General overview of Esocon 40 mg/vial Injection
- Multiple uses of Esocon 40 mg/vial Injection
- Common side effects of Esocon 40 mg/vial Injection
- Considerations for pregnancy and breastfeeding
- Duration for Esocon 40 mg/vial Injection to work
- Quick tips for taking Esocon 40 mg/vial Injection
Related Brands
- Esocon 40 mg (Capsule (Enteric Coated)) - biopharma-limited
- Esocon 20 mg (Capsule (Enteric Coated)) - biopharma-limited
- Esocare 40 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- Esocare 20 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- ESO 20 mg (Tablet (Enteric Coated)) - asiatic-laboratories-ltd